Literature DB >> 26775046

Plateaued national utilization of adolescent bariatric surgery despite increasing prevalence of obesity-associated co-morbidities.

Tammy L Kindel1, Daniel Lomelin2, Corrigan McBride2, Vishal Kothari2, Dmitry Oleynikov2.   

Abstract

BACKGROUND: The number of adolescent bariatric surgeries (ABS) performed from 2003 to 2009 has been stable despite reports of an increase in adolescent morbid obesity.
OBJECTIVES: We sought to determine the trend in national ABS volume and the changes in obesity-associated co-morbidities (OACM) from 2004 to 2011.
SETTING: The Healthcare Cost and Utilization Project National Inpatient Sample database.
METHODS: The National Inpatient Sample database was queried for adolescents undergoing Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy from 2004 to 2011. Twelve OACM categories were created by ICD-9 code.
RESULTS: From 2004 to 2011, an estimated 968 ABS cases per year were performed with no significant change in yearly volumes. There was a significant decrease in the annual volume of Roux-en-Y gastric bypasses (85.7%-54.4%, P<.001) with a significant increase in the number of adjustable gastric bandings (13.6%-18.9%, P = .002) and sleeve gastrectomies (.7%-26.7%, P<.001). The mean patient age was 18.0±1.3 years, and 76% of patients were female. The average number of OACMs per adolescent increased significantly, from 1.44±1.3 in 2004-2005 to 1.85±1.5 in 2010-2011 (P<.001). There was a significant increase over time in the prevalence of preoperative obstructive sleep apnea (15.6%-26.8%, P<.001), hypertension (16.6%-24.2%, P = .006), hyperlipidemia (10.2%-15.4%, P = .021), and fatty liver disease (5.2%-10.5%, P = .004).
CONCLUSIONS: There was a significant increase in OACMs for patients undergoing ABS. Despite the increase in OACMs, there has not been a concomitant increase in the number of ABS performed as of 2011. Given the increase in OACMs, these data support efforts to address barriers to adolescent bariatric surgical evaluation and treatment.
Copyright © 2016 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent bariatric surgery; Co-morbidities; Fatty liver disease; Gastric bypass; Surgery utilization

Mesh:

Year:  2015        PMID: 26775046     DOI: 10.1016/j.soard.2015.09.010

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  5 in total

1.  An innovative technique using a percutaneously placed guidewire allows for higher success rate for ERCP compared to balloon enteroscopy assistance in Roux-en-Y gastric bypass anatomy.

Authors:  Tarek Sawas; Andrew C Storm; Fateh Bazerbachi; Chad J Fleming; Eric J Vargas; Vinay Chandrasekhara; James C Andrews; Michael J Levy; John A Martin; Bret T Petersen; Mark D Topazian; Barham K Abu Dayyeh
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

2.  Health Disparities in Adolescent Bariatric Surgery: Nationwide Outcomes and Utilization.

Authors:  Omar Nunez Lopez; Daniel C Jupiter; Fredrick J Bohanon; Ravi S Radhakrishnan; Kanika A Bowen-Jallow
Journal:  J Adolesc Health       Date:  2017-09-01       Impact factor: 5.012

Review 3.  Long-Term Outcome of Bariatric Surgery in Morbidly Obese Adolescents: a Systematic Review and Meta-Analysis of 950 Patients with a Minimum of 3 years Follow-Up.

Authors:  Saeed Shoar; Habibollah Mahmoudzadeh; Mohammad Naderan; Shahram Bagheri-Hariri; Catherine Wong; Ahmad Shahabeddin Parizi; Nasrin Shoar
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

4.  Impact of the COVID-19 Pandemic on Metabolic and Bariatric Surgery Utilization and Safety in the United States.

Authors:  Sarah E Messiah; Luyu Xie; Matthew Sunil Mathew; Elisa Marroquin Marroquín; Jaime P Almandoz; Faisal G Qureshi; Benjamin E Schneider; Nestor de la Cruz-Muñoz
Journal:  Obes Surg       Date:  2022-05-02       Impact factor: 3.479

5.  Trend Analysis of Aggregate Outcomes in Complex Health Survey Data.

Authors:  Wesley M Durand; Paul C Stey; Elizabeth S Chen; Indra Neil Sarkar
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2018-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.